Mation. J Bone Miner Res. 2014; 29(four):86677. 23. Osipo C, Golde TE, Osborne BA, Miele LA. Off the beaten pathway: the complicated cross talk amongst Notch and NF-B. Lab Invest. 2008;88(1):117. 24. Schwarzer R, Jundt F. Notch and NF-B signaling pathways within the biology of classical Hodgkin lymphoma. Curr Mol Med. 2011;11(3):23645. 25. Maniati E, et al. Crosstalk involving the canonical NF-B and Notch signaling pathways inhibits Ppar expression and promotes pancreatic cancer progression in mice. J Clin Invest. 2011; 121(12):4685699. 26. Hansson EM, Lendahl U, Chapman G. Notch signaling in development and disease. Semin Cancer Biol. 2004;14(five):32028. 27. Wright TW, Pryhuber GS, Chess PR, Wang Z, Notter RH, Gigliotti F. TNF receptor signaling contributes to chemokine secretion, inflammation, and respihttp://www.jci.org VolumeThe Journal of Clinical InvestigationNumberresearch article41. Zhao B, Grimes SN, Li S, Hu X, Ivashkiv LB. TNFinduced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription element RBP-J. J Exp Med. 2012;209(2):31934. 42. Xu H, et al. Notch-RBP-J signaling regulates the transcription issue IRF8 to market inflammatory macrophage polarization. Nat Immunol. 2012; 13(7):64250. 43. Brownlow N, Mol C, Hayford C, Ghaem-Maghami S, Dibb NJ. Dasatinib is often a potent inhibitor of tumour-associated macrophages, osteoclasts as well as the FMS receptor. Leukemia. 2009;23(3):59094. 44. Bai S, et al. NOTCH1 regulates osteoclastogenesis straight in osteoclast precursors and indirectly by way of osteoblast lineage cells. J Biol Chem. 2008; 283(ten):6509518. 45. Ando K, et al. Induction of Notch signaling by tumor necrosis factor in rheumatoid synovial fibroblasts. Oncogene. 2003;22(49):7796803. 46. Okamoto T. The epigenetic alteration of synovial cell gene expression in rheumatoid arthritis and also the roles of nuclear aspect B and Notch signaling pathways. Mod Rheumatol. 2005;15(2):796. 47. Gao W, et al. Notch-1 mediates hypoxia-induced angiogenesis in rheumatoid arthritis. Arthritis Rheum. 2012;64(7):2104113. 48. Park JS, et al. Inhibition of Notch signalling ameliorates experimental inflammatory arthritis [published on-line ahead of print November 19, 2013]. Ann Rheum Dis. doi:ten.1136/annrheumdis2013-203467. 49. Sekine C, Koyanagi A, Koyama N, Hozumi K, Chiba S, Yagita H.Ledipasvir Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes.Perindopril erbumine Arthritis Res Ther.PMID:24059181 2012;14(2):R45. 50. Fernandez L, et al. Tumor necrosis factor- and endothelial cells modulate Notch signaling within the bone marrow microenvironment in the course of inflammation. Exp Hematol. 2008;36(5):54558. 51. Acharyya S, et al. TNF inhibits Notch-1 in skeletal muscle cells by Ezh2 and DNA methylation mediated repression: implications in duchenne muscular dystrophy. PLoS One particular. 2010;5(eight):e12479. 52. Tao J, Chen S, Lee B. Alteration of Notch signaling in skeletal development and disease. Ann N Y Acad Sci. 2010;1192:25768. 53. Zetterberg H, Mattsson N, Blennow K, Olsson B. Use of theragnostic markers to select drugs for phase II/III trials for Alzheimer disease. Alzheimers Res Ther. 2010;two(six):32. 54. Park D, et al. Endogenous bone marrow MSCs are dynamic, fate-restricted participants in bone maintenance and regeneration. Cell Stem Cell. 2012; ten(3):25972. 55. Yao Z, Xing L, Boyce BF. NF-B p100 limits TNF-induced bone resorption in mice by a TRAF3-dependent mechanism. J Clin Invest. 2009; 119(ten):3024034. 56. Pryhuber GS, et al. Parenchymal cell TNF receptors contribu.